USAEUROPEViVE
ABOUTSPONSORSHIPFOUNDATION
Logo Hlth
Logo Hlth
05 Jan 2022 | 03:45 PM GMT
Past Meeting

Companion DTx: Clinical and economic evidence

Participants:

Alexander Klein Founder & CEONedicareHealth System & Providers
Health System & Providers
Alexander Klein
Founder & CEONedicare
Matt Norton VP of Marketing & Commercial DevelopmentS3 Connected HealthProfessional Services
Professional Services
Matt Norton
VP of Marketing & Commercial DevelopmentS3 Connected Health
Chandana Fitzgerald President, CommunityHLTHOther
Other
Chandana Fitzgerald
President, CommunityHLTH
Abhishek Shah Co-Founder & CEOWellthy Therapeutics Pvt. Ltd.
Abhishek Shah
Co-Founder & CEOWellthy Therapeutics Pvt. Ltd.
Adam Abrahami Senior ConsultantMaya HealthOther
Other
Adam Abrahami
Senior ConsultantMaya Health
Chris Wasden Chief Strategy OfficerTwillOther
Other
Chris Wasden
Chief Strategy OfficerTwill
Christopher Hall Commercial Director, APACMarula Health
Christopher Hall
Commercial Director, APACMarula Health
Dr. Nick (Nemanja) Kovacev Head of Healthcare and Life Sciences PracticeHTEC GroupHealth Tech & Solutions
Health Tech & Solutions
Dr. Nick (Nemanja) Kovacev
Head of Healthcare and Life Sciences PracticeHTEC Group
Jin Lee Director of Digital HealthAstellas Pharma, IncOther
Other
Jin Lee
Director of Digital HealthAstellas Pharma, Inc
Klaus Suwelack NBD & Innovation ManagmentJanssenInvestor & Accelerators
Investor & Accelerators
Klaus Suwelack
NBD & Innovation ManagmentJanssen
Mark Grossman VP of Growth Initiatives & Market PartnersGoMo Health - Engagement that WorksHealth Tech & Solutions
Health Tech & Solutions
Mark Grossman
VP of Growth Initiatives & Market PartnersGoMo Health - Engagement that Works
Richie Bavasso PresidentPneumoWave
Richie Bavasso
PresidentPneumoWave

About this Meeting

Commercialization of DTx solutions as digital drug companions seems to be a valuable route to market for DTx companies and a good option for pharma companies, which are still wary of incorporating standalone DTx in their portfolios. However, there are still a lot of questions around the evidence generation for companion DTx. Join us in this informal conversation where we will talk about:   

  •  Level of clinical and economic evidence required - how does this change depending on the stakeholder, mode of action, risk of the product, etc?
  •  Companion DTx and drugs are currently regulated separately; but when it comes to clinical evidence, should DTx - drug be validated together? What are the barriers and challenges to do this?  
  •  Particularities of the study design for companion DTx.  
  •  Role of the DTx company vs. role of pharma in evidence generation  
  •  What is the most efficient way to generate economic evidence?

About Us

HLTH Inc. is a dynamic community delivering unique value to the healthcare industry through a mix of unparalleled global events, inspirational content, and impact-driven initiatives.

USA Event Dates

  • 2026 | HLTH: Nov 15 – 18 | Las Vegas, NV | Register | Sponsor
  • 2027 | ViVE: Mar 14 – 17 | Nashville, TN | Be First to Know | Sponsor
  • 2027 | HLTH: Oct 17 – 20 | Las Vegas, NV
  • 2028 | HLTH: Nov 12 – 15 | Las Vegas, NV

Europe Event Dates

  • 2027 | HLTH Europe: Jun 21 – 24 | Amsterdam | Sponsor
  • 2028 | HLTH Europe: Jun 19 – 22 | Amsterdam

Important Notice on Hotel Scams

Any communication that claims to represent HLTH or any third party offering discounted hotel rooms or attendee lists is NOT AFFILIATED with HLTH and should be considered fraudulent. Please book your accommodations only through HLTH’s official channels to ensure authenticity and security.

© 2026 HLTH, INC. by Hyve Group - All Rights Reserved

About usPrivacy Policy Contact us